RUNX1 and myelodysplastic syndrome: Intriguingly, the RUNX1 mutation was observed at an approx. VAF of 50%, despite the obvious phenotypical heterogeneity with typical BPDCN, infiltrates alongside cells more typical of pDC-like AML emerging from an MDS, suggesting a partially shared clonal architecture.